Company Encyclopedia
View More
name
MGI
688114.SH
MGI Tech Co., Ltd. engages in the research, development, production, and sale of DNA sequencing instruments, reagents, and related products for precision medicine, agriculture, healthcare, and other relevant industries in China and internationally. Its products include sequencers, such as genetic sequencers, sequencing reagents, library prep kits multiplex immunofluorescence reagent staining sets, and bioinformatics analysis; lab automation products comprising sample pretreatment products, sample preparation platforms, and integrated testing platforms; novel products, including STOmics, cell omics, ultrasound, BIT, and sample storage products, as well as microneedling products. MGI Tech Co., Ltd.
564.01 B
688114.SHMarket value -Rank by Market Cap -/-

Financial Score

11/12/2025 Update
C
Life Sciences Tools and ServicesIndustry
Industry Ranking13/27
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-3.27%D
    • Profit Margin-8.53%D
    • Gross Margin64.31%A
  • Growth ScoreB
    • Revenue YoY16.92%B
    • Net Profit YoY70.56%A
    • Total Assets YoY1.88%C
    • Net Assets YoY-3.26%D
  • Cash ScoreC
    • Cash Flow Margin-1172.10%E
    • OCF YoY16.92%B
  • Operating ScoreD
    • Turnover0.3D
  • Debt ScoreB
    • Gearing Ratio23.69%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Shenzhen-based MGI "sells technology" and will receive no less than $120 million in licensing fees

    Shenzhen MGI Technology Co., Ltd. has reached a technology licensing cooperation with Swiss biotechnology company Swiss Rockets AG through its U.S. subsidiary, granting exclusive and non-exclusive licenses for its "CoolMPS" sequencing technology-related patents to Swiss Rockets. This cooperation is expected to bring MGI no less than USD 120 million in licensing fees

    Zhitong·
    SH
    688114
    -1.27%
    Zhitong·
    SH
    688114
    -1.27%

    MGI and Xihu Yiming have formed a strategic partnership to jointly launch a high-throughput immune health monitoring solution

    According to the official WeChat account of MGI, on October 24th, at the 20th International Genomics Conference, Xihu Yiming Biotechnology Co., Ltd. and MGI announced a deep strategic cooperation. The two parties will jointly launch a high-throughput immune health monitoring program aimed at the general consumer, exploring more application scenarios in areas such as anti-infection immunity, allergies, food intolerance, body aging, and disease warning

    Zhitong·
    SH
    688114
    -1.27%
    Zhitong·
    SH
    688114
    -1.27%

    MGI clarifies rumors about car manufacturing: it is not "manufacturing cars" but "using cars" as a mobile platform

    MGI clarified recent rumors about car manufacturing, emphasizing that its business is not about making cars, but rather using vehicles as mobile platforms. The company focuses on the research and development of life science technology tools and has launched various mobile platforms equipped with core devices, serving the medical and public health sectors. At the same time, MGI has established a new company in Beijing, with a business scope that includes the sale of automotive parts

    Zhitong·
    SH
    688114
    -1.27%
    Zhitong·
    SH
    688114
    -1.27%

    Shenzhen Guochuang Zhongke signed a strategic cooperation agreement with MGI

    According to the official WeChat account of MGI, on October 17th, a delegation from Shenzhen Guochuang Zhongke Medical Technology Co., Ltd. visited the Shenzhen BGI Space Center and officially signed a strategic cooperation agreement with MGI. This cooperation will be based on MGI's Bloomics® single-use peripheral blood collection system, combined with Shenzhen Guochuang Zhongke Medical Technology Co., Ltd.'s resources and experience in the home testing field, to carry out deeper cooperation and jointly promote the development of the domestic consumer health sector, creating a new model for health management

    Zhitong·
    SH
    688114
    -1.27%
    Zhitong·
    SH
    688114
    -1.27%

    Zhitong A-share lock-up release overview | October 21

    On October 21, a total of 4 listed companies had their restricted shares unlocked, with a total market value of approximately 2.531 billion yuan. The specific situation of the restricted shares unlocked today is as follows: Stock Abbreviation Stock Code Restricted Share Type Unlocked Shares WESTERN REGION GOLD 601069 Equity Incentive Restricted Circulation 2.0741 million JIARONG 301148 Extended Restricted Lock-up Period Circulation 7.6832 million MGI 688114 1.2247 million Cellwise 688325 2.6157 million

    Zhitong·
    SH
    601069
    -2.23%
    SZ
    301148
    -3.03%
    SH
    688325
    +0.55%
    Zhitong·
    SH
    601069
    -2.23%
    SZ
    301148
    -3.03%
    SH
    688325
    +0.55%
    © 2025 Longbridge｜Disclaimer